These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 16523196)
1. The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer. Lamb GW; McMillan DC; Ramsey S; Aitchison M Br J Cancer; 2006 Mar; 94(6):781-4. PubMed ID: 16523196 [TBL] [Abstract][Full Text] [Related]
2. Prospective study of the role of inflammation in renal cancer. Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628 [TBL] [Abstract][Full Text] [Related]
3. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. Ramsey S; Lamb GW; Aitchison M; McMillan DC BJU Int; 2008 Apr; 101(8):959-63. PubMed ID: 18190639 [TBL] [Abstract][Full Text] [Related]
4. The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. Bromwich E; McMillan DC; Lamb GW; Vasey PA; Aitchison M Br J Cancer; 2004 Oct; 91(7):1236-8. PubMed ID: 15354220 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy. Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582 [TBL] [Abstract][Full Text] [Related]
6. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA J Urol; 2010 Feb; 183(2):480-5. PubMed ID: 20006861 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma. Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084 [TBL] [Abstract][Full Text] [Related]
8. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer. Ramsey S; Lamb GW; Aitchison M; McMillan DC Br J Cancer; 2006 Oct; 95(8):1076-80. PubMed ID: 17003778 [TBL] [Abstract][Full Text] [Related]
9. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550 [TBL] [Abstract][Full Text] [Related]
10. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. Lamb GW; McArdle PA; Ramsey S; McNichol AM; Edwards J; Aitchison M; McMillan DC BJU Int; 2008 Sep; 102(6):756-61. PubMed ID: 18384626 [TBL] [Abstract][Full Text] [Related]
11. The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Canna K; Hilmy M; McMillan DC; Smith GW; McKee RF; McArdle CS; McNicol AM Colorectal Dis; 2008 Sep; 10(7):663-7. PubMed ID: 18005189 [TBL] [Abstract][Full Text] [Related]
13. Impact of postoperative C-reactive protein level on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma. Ito K; Yoshii H; Sato A; Kuroda K; Asakuma J; Horiguchi A; Sumitomo M; Asano T J Urol; 2011 Aug; 186(2):430-5. PubMed ID: 21679988 [TBL] [Abstract][Full Text] [Related]
14. Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. Lamb GW; Aitchison M; Ramsey S; Housley SL; McMillan DC Br J Cancer; 2012 Jan; 106(2):279-83. PubMed ID: 22166802 [TBL] [Abstract][Full Text] [Related]
15. Systemic inflammatory response and survival in patients with localised prostate cancer: 10-year follow-up. McArdle PA; Qayyum T; McMillan DC Urol Int; 2010; 84(4):430-5. PubMed ID: 20395655 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105 [TBL] [Abstract][Full Text] [Related]
19. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma. Ficarra V; Novara G; Galfano A; Brunelli M; Cavalleri S; Martignoni G; Artibani W BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313 [TBL] [Abstract][Full Text] [Related]
20. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC Br J Cancer; 2006 Jun; 94(12):1833-6. PubMed ID: 16721360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]